Investigate how microglial senescence drives ALS progression through inflammation, trophic support loss, and protein aggregation. Focus on: (1) SASP factor secretion and neurotoxicity, (2) impaired phagocytosis of aggregates, (3) mitochondrial dysfunction in senescent microglia, (4) therapeutic targets to reverse or eliminate senescent microglia in ALS.
This hypothesis proposes that loss-of-function mutations in TBK1 contribute to ALS pathogenesis primarily through disrupted mitochondrial quality control in motor neurons, leading to bioenergetic failure and selective neuronal death. TBK1 normally phosphorylates autophagy receptors OPTN and p62, which are essential for targeting damaged mitochondria for mitophagy. When TBK1 function is lost, defective mitochondria accumulate in motor neurons, causing oxidative stress, ATP depletion, and ultimately cell death. Supporting evidence includes phospho-proteome profiling in human neurons (Smeyers et al., Cell Rep 2025) showing that ALS/FTD-associated TBK1 substrates are predominantly neuronal autophagy proteins (FIP200, OPTN, p62) rather than inflammatory mediators.
...
This hypothesis proposes that loss-of-function mutations in TBK1 contribute to ALS pathogenesis primarily through disrupted mitochondrial quality control in motor neurons, leading to bioenergetic failure and selective neuronal death. TBK1 normally phosphorylates autophagy receptors OPTN and p62, which are essential for targeting damaged mitochondria for mitophagy. When TBK1 function is lost, defective mitochondria accumulate in motor neurons, causing oxidative stress, ATP depletion, and ultimately cell death. Supporting evidence includes phospho-proteome profiling in human neurons (Smeyers et al., Cell Rep 2025) showing that ALS/FTD-associated TBK1 substrates are predominantly neuronal autophagy proteins (FIP200, OPTN, p62) rather than inflammatory mediators. Motor neurons are particularly vulnerable due to their high metabolic demands, long axonal projections requiring extensive mitochondrial transport, and limited regenerative capacity. The 2025 Nat Commun study, while highlighting microglial changes, may reflect secondary neuroinflammation responding to primary motor neuron damage rather than the initiating pathogenic event. Human genetic evidence supports this model: TBK1 haploinsufficiency causes familial ALS/FTD, and mutations in other mitophagy-related genes (OPTN, p62/SQSTM1) also cause ALS, suggesting convergent pathways. Contradictory evidence includes the Cell (2018) study linking TBK1 to RIPK1-driven inflammation, but this inflammatory axis may be secondary to metabolic dysfunction. Additionally, while TDP-43 pathology activates cGAS-STING signaling (Cell 2020), this could represent a downstream consequence of mitochondrial DNA release from damaged mitochondria rather than the primary pathogenic mechanism. This model positions mitochondrial dysfunction as the central pathogenic hub, with neuroinflammation and other ALS hallmarks arising secondarily from bioenergetic collapse.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["dsDNA/dsRNA or Bacteria STING/MAVS Signal"]
B["TBK1 Activation IKK-epsilon Complex"]
C["IRF3 Phosphorylation Ser396 by TBK1"]
D["IRF3 Dimerization Nuclear Import"]
E["Type-I IFN Expression IFN-beta/IFN-alpha"]
F["Antiviral Defense ISG Upregulation"]
G["TBK1 Loss-of-Function ALS10 Mutations"]
H["OPTN/p62 Phosphorylation Selective Autophagy"]
A --> B
B --> C
B --> H
C --> D
D --> E
E --> F
G -.->|"impairs"| B
G -.->|"impairs"| H
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#1b5e20,stroke:#81c784,color:#81c784
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
Median TPM across 13 brain regions for TBK1 → OPTN / p62 / FIP200 / mitophagy machinery from GTEx v10.
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
Manganelli F et al., Cells 2026 Mar 6 · PMID:41827910
No claimMODERATE
Smeyers J et al., Cell Rep 2025 Nov 25 · PMID:41171761
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Scientific Skeptic Assessment: TBK1 Loss/Microglial Senescence Hypothesis in ALS
Executive Summary
The hypothesis proposes a coherent and mechanistically plausible model linking TBK1 loss-of-function mutations to ALS pathogenesis through microglial senescence and SASP. While supported by compelling animal model data and consistent with known roles for TBK1 in inflammatory signaling, this framework faces significant challenges from the prevailing evidence suggesting neuronal autophagy dysfunction as the primary TBK1-dependent pathogenic mechanism. I identify critical gaps in causal evi
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
Scientific Synthesis: TBK1 Loss/Microglial Senescence Hypothesis in ALS
Integration of Prior Arguments
The Core Tension
The debate crystallizes around a fundamental question: Is the primary TBK1 pathogenic axis neuronal (autophagy/proteostasis) or microglial (senescence/SASP)?
The Theorist presents compelling circumstantial evidence: microglia-specific TBK1 deletion reproduces aged transcriptional signatures, RIPK1-driven inflammation emerges from TBK1 insufficiency, and cGAS-STING activation downstream provides mechanistic plausibility. The Skeptic counters with pho
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.